🩺 Diabetes boosts sudden cardiac death risk

Diabetes was found to be linked with a higher risk of sudden cardiac death, even without obstructive coronary artery disease. Researchers analyzed 22,395 patients in a Finnish hospital from 2007 to 2018. Post-adjustment, diabetes showed a higher risk for SCD (SHR, 1.38) and a similar association with non-SCD. In patients with diabetes and CAD, revascularisation lowered SCD risk compared to medical therapy alone. The findings emphasize the need for better risk stratification in diabetic individuals. 🩺

🩺 GLP-1s might help dialysis patients with inflammation

A real-world study found that GLP-1 receptor agonist users had better markers in kidney failure patients. This involved 2468 patients who received or did not receive GLP-1 RAs over 12 months. Users showed lower NLR and WBC counts, plus needed less ESA treatment compared to nonusers. Furthermore, GLP-1 RA users had higher ferritin and serum albumin levels at the 12-month mark. These results suggest GLP-1 RAs could benefit inflammation and anemia management in kidney failure. 🩺

🔬 OSCC drug delivery needs tumor-specific approach

A new review examines mucoadhesive films, hydrogels, and sprays for treating oral squamous cell carcinoma (OSCC). Researchers from Indonesia, Japan, and China emphasize that no single formulation suits every tumor. The study highlights that tumor shape, oral environment, and patient context must guide strategy. While films are straightforward, complex tumors might need injectable hydrogels. Future work must test these systems under realistic clinical conditions. 🔬

🍎 Healthy eating might boost lung health for asthma/COPD patients

A healthier diet was found to correlate with better lung function in adults with asthma or COPD. Researchers analyzed data from the Lifelines cohort in the Netherlands, involving 83,460 participants. The study tracked participants for five years, with 9% having asthma and 15% having COPD. Higher diet scores were linked to slower lung function decline in COPD patients over time. This suggests diet could be an accessible strategy alongside medical treatments. 🍎

🎬 Anne Hathaway hits $2B box office in 2026

Anne Hathaway's 2026 global box office total has surpassed the $2 billion milestone across four film releases. These four projects spanned different genres, with the biggest contributors being The Odyssey and The Devil Wears Prada 2. So far, the cumulative worldwide gross is $2.235 billion as of this update. The Odyssey alone has collected $1.45 billion worldwide, showing major impact. She still has one more film, Verity, set for release in October 2026.

🩺 AI beats gene sequencing for lung nodule risk

An AI-based radiomics tool proved more effective than genomic sequencing for risk stratification of incidental pulmonary nodules. This study was conducted by Christina Bellinger, MD, at Wake Forest University School of Medicine in Winston-Salem, North Carolina. The researchers analyzed data from 59 patients, comparing the Lung Cancer Prediction Score (LCP Score) against a Genomic Sequence Classifier (GSC). Overall, the LCP showed greater accuracy with an AUC of 0.82 versus 0.59 for GSC. Future larger prospective studies are necessary to confirm if routine AI use improves patient outcomes. 🩺

🚀 Irumudi climbs toward super hit status

Ravi Teja's Irumudi is nearing the super hit mark despite competition from Yash's Toxic. The film grossed 100.6 crore overall, with Day 6 collections hitting 10.2 crore in India. Over six days, the movie secured a net collection of 85.25 crore against a 35 crore budget. This performance has already earned it a 'Hit' verdict based on ROI parameters. It is expected to officially become a super hit by Day 7. 🎬

🎬 Irumudi targets 3rd spot in Tollywood box office

Ravi Teja's Irumudi is performing well at the worldwide box office, aiming for the 3rd spot among Tollywood's top grossers of 2026. The film grossed 12.79 crore on day 6, with 12.04 crore in India and 75 lakh internationally. In total over six days, its worldwide collection reached 117.85 crore gross. This performance positions it to potentially surpass The RajaSaab and become Ravi Teja's biggest solo success. Fans should keep tracking the film as it heads towards the 200 crore mark.

🎬 Statham's Mutiny needs big jump to beat Shelter

Jason Statham's latest film, Mutiny, is currently performing modestly at the box office. The movie, directed by Jean-François Richet, was released worldwide on August 21 and stars Statham. Currently, its worldwide collection stands at $16.04 million, with a domestic total of $9.4 million after 5 days. To surpass Shelter's $54.6 million worldwide haul, Mutiny needs over a 240% jump. The film's future depends on it maintaining strong momentum in the upcoming weeks. 🎬

📉 Khalifa's box office dip on Onam

Prithviraj Sukumaran's movie Khalifa saw its collections drop significantly by day 7. The film was released during the Onam season in India, featuring cameos by Mohanlal and Tovino Thomas. After 7 days, its net total reached 15.37 crore, while gross collections hit 18.13 crore. Khalifa trailed the competitor Toxic in Kerala, earning 1.5 crore gross compared to Toxic's 2.1 crore gross. The film faces a possible box office disappointment, potentially marking Prithviraj's third consecutive failure. 📉

🔬 Cancer protein BRAF could fight nerve pain

A new preclinical study identified BRAF as a key regulator of pain signaling after nerve injury. Researchers at The University of Texas MD Anderson Cancer Center found this protein plays a role in neuropathic pain development. In models, BRAF inhibitors like vemurafenib reduced pain sensitivity following nerve injury on dates not specified. This suggests existing cancer drugs might be repurposed for chronic nerve pain treatment. Further studies are needed to test this approach in human patients. 🧠